Liraglutide promotes apoptosis of HepG2 cells by activating JNK signaling pathway.

Qingli Li, Xue Ay, Zhenlin Li, Yin ZPubMed 2019 · DOI

Abstract

Liraglutide can promote the apoptosis of hepatocellular carcinoma HepG2 cells in a dose-dependent manner, and its mechanism may act by promoting the activation of the JNK signaling pathway.
BibTeX
@inproceedings{li2019liraglutide,
  author = {Qingli Li and Xue Ay and Zhenlin Li and Yin Z},
  title = {{Liraglutide promotes apoptosis of HepG2 cells by activating JNK signaling pathway.}},
  booktitle = {PubMed},
  year = {2019},
  doi = {10.26355/eurrev\_201904\_17719},
}

Loading related content...

Figure